Moshe Giladi
About Moshe Giladi
Moshe Giladi is the Chief Science Officer at Novocure, based in Haifa District, Israel, with over 18 years of experience in preclinical research and a strong background in microbiology.
Title
Moshe Giladi is the Chief Science Officer at Novocure, a globally recognized oncology company, where he oversees scientific research and development. His role is based in the Haifa District of Israel.
Career at Novocure
Moshe Giladi has a long-standing career at Novocure, spanning over 18 years. Initially, he served as the Head of Preclinical Research from 2005 to 2023, a role in which he was instrumental in advancing the company's preclinical studies. In 2023, he transitioned to the position of Chief Science Officer, continuing his commitment to pioneering cancer treatment research.
Education and Expertise
Moshe Giladi completed his PhD in Microbiology at Tel Aviv University between 2000 and 2005. His academic journey also includes an MBA, which complements his scientific background with business acumen. This combination of degrees underscores his expertise in both scientific research and business management.
Background
Based in Netanya, Center District, Israel, Moshe Giladi works in the Haifa District. His deep understanding of microbiology, gained through his PhD studies, has been a critical asset throughout his career. His education and subsequent roles at Novocure reflect a balance between scientific inquiry and practical application in the field of oncology.
Expert Discussions and Opinions
Moshe Giladi has been featured in an in-depth interview with OncLive, where he discussed the science behind Tumor Treating Fields therapy. He also shares his personal views and opinions on LinkedIn, asserting his independence from his employer in these expressions.